The levels of tumor-associated caspase-4 were defined as low (<0.377 ng/ml) or high (>0.377 ng/ml) according to the cut-off value that derived from the mean of the tissue levels of caspase-4 from non-COPD, non-lung cancer patients (Figure 4A). Here, CASP4 is linked to chronic obstructive pulmonary disease.